| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/01/2023 | TCR2 THERAPEUTICS INC. | TCRR | Disposition | Stock Option (Right to Buy) | 16.8k | $0.97 | $16.3k | | 06/01/2023 |
| 06/01/2023 | TCR2 THERAPEUTICS INC. | TCRR | Disposition | Stock Option (Right to Buy) | 12.1k | $5.21 | $63k | | 06/01/2023 |
| 06/01/2023 | TCR2 THERAPEUTICS INC. | TCRR | Disposition | Stock Option (Right to Buy) | 15.2k | $26.33 | $400k | | 06/01/2023 |
| 06/01/2023 | TCR2 THERAPEUTICS INC. | TCRR | Disposition | Stock Option (Right to Buy) | 4.2k | $26.33 | $110k | | 06/01/2023 |
| 05/23/2023 | 4D Molecular Therapeutics, Inc. | FDMT | Grant | Stock Option (Right to Buy) | 22.5k | $17.98 | $404.6k | | 05/23/2023 |
| 05/11/2023 | Allovir, Inc. | ALVR | Grant | Common Stock | 35k | $0.00 | $0 | | 05/11/2023 |
| 03/20/2023 | Gamida Cell Ltd. | GMDA | Grant | Share Option (Right to Buy) | 17k | $1.32 | $22.4k | | 03/20/2023 |
| 12/15/2022 | TCR2 THERAPEUTICS INC. | TCRR | Grant | Stock Option (Right to Buy) | 16.8k | $0.97 | $16.3k | | 12/15/2022 |
| 11/18/2022 | Gamida Cell Ltd. | GMDA | Grant | Ordinary Shares | 2k | $0.00 | $0 | | 11/18/2022 |
| 11/18/2022 | Gamida Cell Ltd. | GMDA | Grant | Share Option (Right to Buy) | 9.5k | $1.79 | $17k | | 11/18/2022 |
| 09/30/2022 | Gamida Cell Ltd. | GMDA | Purchase | Ordinary Shares | 9.7k | $1.55 | $15k | | 09/30/2022 |
| 05/23/2022 | 4D Molecular Therapeutics, Inc. | FDMT | Grant | Stock Option (Right to Buy) | 22.5k | $7.77 | $174.8k | | 05/23/2022 |
| 05/17/2022 | Allovir, Inc. | ALVR | Grant | Stock Option (Right to Buy) | 27.5k | $4.60 | $126.5k | | 05/17/2022 |
| 12/09/2021 | TCR2 THERAPEUTICS INC. | TCRR | Grant | Stock Option (Right to Buy) | 12.1k | $5.21 | $63k | | 12/09/2021 |
| 06/07/2021 | UroGen Pharma Ltd. | URGN | Grant | Stock Option (right to buy) | 10k | $17.98 | $179.8k | | 06/07/2021 |
| 05/17/2021 | 4D Molecular Therapeutics, Inc. | FDMT | Grant | Stock Option (Right to Buy) | 22.5k | $26.89 | $605k | | 05/17/2021 |
| 02/03/2021 | TCR2 THERAPEUTICS INC. | TCRR | Grant | Stock Option (Right to Buy) | 15.2k | $26.33 | $400k | | 02/03/2021 |
| 02/03/2021 | TCR2 THERAPEUTICS INC. | TCRR | Grant | Stock Option (Right to Buy) | 4.2k | $26.33 | $110k | | 02/03/2021 |
| 09/28/2020 | Principia Biopharma Inc. | PRNB | Disposition | Director Stock Option (right to buy) | 10.2k | $62.66 | $641.6k | | 09/28/2020 |
| 09/28/2020 | Principia Biopharma Inc. | PRNB | Disposition | Director Stock Option (right to buy) | 20.5k | $36.79 | $753.3k | | 09/28/2020 |
| 06/08/2020 | UroGen Pharma Ltd. | URGN | Grant | Stock Option (right to buy) | 10k | $28.24 | $282.4k | | 06/08/2020 |
| 06/04/2020 | Principia Biopharma Inc. | PRNB | Grant | Director Stock Option (right to buy) | 10.2k | $62.66 | $641.6k | | 06/04/2020 |
| 05/20/2020 | ABEONA THERAPEUTICS INC. | ABEO | Grant | Common Stock | 35.9k | $0.00 | $0 | | 05/20/2020 |
| 05/20/2020 | ABEONA THERAPEUTICS INC. | ABEO | Grant | Stock Option (right to buy) | 43k | $3.20 | $137.7k | | 05/20/2020 |
| 02/10/2020 | Diplomat Pharmacy, Inc. | DPLO | Other | Common Stock | 11.3k | $4.00 | $45.1k | | 02/10/2020 |
| 02/10/2020 | Diplomat Pharmacy, Inc. | DPLO | Disposition | Common Stock | 33.3k | $4.00 | $133k | | 02/10/2020 |
| 08/29/2019 | Principia Biopharma Inc. | PRNB | Grant | Director Stock Option (right to buy) | 20.5k | $36.79 | $753.3k | | 08/29/2019 |
| 08/29/2019 | Principia Biopharma Inc. | PRNB | Grant | Director Stock Option (right to buy) | 10.2k | $36.79 | $376.7k | | 08/29/2019 |
| 08/29/2019 | Principia Biopharma Inc. | PRNB | Grant | Director Stock Option (right to buy) | 20.5k | $36.79 | $753.3k | | 08/29/2019 |
| 06/04/2019 | Diplomat Pharmacy, Inc. | DPLO | Sale | Common Stock | 1.3k | $4.85 | $6.2k | | 06/03/2019 |
| 06/03/2019 | UroGen Pharma Ltd. | URGN | Grant | Stock Option (Right to Buy) | 10k | $34.83 | $348.3k | | 06/03/2019 |
| 06/03/2019 | Diplomat Pharmacy, Inc. | DPLO | Grant | Common Stock | 33.3k | $0.00 | $0 | | 06/03/2019 |
| 06/05/2018 | Diplomat Pharmacy, Inc. | DPLO | Sale | Common Stock | 1.7k | $24.27 | $40.8k | | 06/01/2018 |
| 06/01/2018 | Diplomat Pharmacy, Inc. | DPLO | Grant | Common Stock | 3.7k | $0.00 | $0 | | 06/01/2018 |
| 09/25/2017 | Kite Pharma, Inc. | KITE | Grant | Common Stock | 4.5k | $0.00 | $0 | | 09/25/2017 |
|